XML 81 R61.htm IDEA: XBRL DOCUMENT v3.23.1
Fair Value Measurements - Schedule of Changes in the Fair Value of Level 3 Financial Instruments (Details) - Level 3 - USD ($)
$ in Thousands
12 Months Ended
Jan. 31, 2023
Jan. 31, 2022
Jan. 31, 2021
Common stock and preferred stock warrants | Redeemable convertible preferred stock warrant      
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]      
Beginning balance $ 0 $ (75,843) $ (2,718)
Change in fair value   9,237 73,125
Reclassification of Legacy ChargePoint preferred stock warrant liability upon the reverse capitalization   66,606  
Ending balance 0 0 (75,843)
Common stock and preferred stock warrants | Private Placement Warrants      
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]      
Beginning balance (25) 0 0
Private placement warrant liability acquired as part of the Merger   (127,888)  
Change in fair value 23 63,746  
Reclassification of warrants to stockholders’ equity (deficit) due to exercise 48 64,117  
Ending balance 0 (25) 0
Contingent Consideration Liability      
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]      
Beginning balance 0 0 0
Contingent earnout liability recognized upon the closing of the reverse recapitalization   (828,180)  
Change in fair value   84,420  
Issuance of earnout shares upon triggering events   501,120  
Reclassification of remaining contingent earnout liability upon triggering event   242,640  
Ending balance 0 0 0
Contingent Consideration Liability | ViriCiti Earnout liability      
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]      
Beginning balance (5,993) 0 0
Contingent earnout liability recognized upon the acquisition of ViriCiti (“ViriCiti Earnout”) (1,283) (3,856)  
Transfer out of Level 3 upon achievement of earnings target for the earnout period 7,085    
Change in fair value   (2,137)  
Ending balance 0 $ (5,993) $ 0
Contingent Consideration Liability | Private Placement Warrants | ViriCiti Earnout liability      
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]      
Effect of foreign currency translation $ 191